San Francisco, 24 October 2018 - The global pharmacogenomics technology (theranostics and companiondiagnostics) market is expected to reach USD 18.3 billion by 2025, according to a new report by Grand View Research, Inc. Diagnostics is coming to grips with the wave of pharmacogenomic tests that are followed by new biological therapy introductions. These tests enable cost-effective treatment and also add value to the process of drug-development. Advantages associated with the usage of these tests such as disease risk prediction, patient stratification, and therapeutic response monitoring over the traditional methods is anticipated to significant source of progress in this market.
In addition, pharmacogenomics testing products aid physicians in individualizing and optimization of patient’s therapeutic regimen. Pharmacogenomics and theranostics are paving the way for integrated medicine. Rapid evolution in this group of specialized molecular diagnostic tests are contributing in improvement for assessment of real-time treatment of disease. However, presence of challenges pertaining to early integration of pharmacogenomic based testing into drug development time lines for gaining the approval simultaneously is anticipated to impede growth. Proper designing and implementation of clinical trials in order to identify individual as well as population variations from a given therapy has become a necessary attribute for the success of theranostics. Full Research Report On Global Pharmacogenomics Technology Market By Grand View Research: www.grandviewresearch.com/industry-analysis/pharmacogenomics-technology-theranostics-companion-diagnostics-cdx-market Further key findings from the study suggest:
www.grandviewresearch.com/industry/clinical-diagnostics Grand View Research has segmented the pharmacogenomics technology (theranostics and companion diagnostics) market on the basis of therapeutic area, technology, and region: Therapeutic Area Outlook (Revenue, USD Million; 2014 - 2025)
www.grandviewresearch.com/press-release/global-pharmacogenomics-technology-theranostics-companion-diagnostics-cdx-market About Grand View Research Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare. For More Information: www.grandviewresearch.com
0 Comments
Leave a Reply. |